Klepstad P - Search Results

1

Effects of hypothermia on the disposition of morphine, midazolam, fentanyl, and propofol in intensive care unit patients.

Bjelland TW, Klepstad P, Haugen BO, Nilsen T, Dale O. Bjelland TW, et al. Among authors: klepstad p. Drug Metab Dispos. 2013 Jan;41(1):214-23. doi: 10.1124/dmd.112.045567. Epub 2012 Oct 31. Drug Metab Dispos. 2013. PMID: 23115086 Clinical Trial.

2

Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy.

Holthe M, Klepstad P, Zahlsen K, Borchgrevink PC, Hagen L, Dale O, Kaasa S, Krokan HE, Skorpen F. Holthe M, et al. Among authors: klepstad p. Eur J Clin Pharmacol. 2002 Aug;58(5):353-6. doi: 10.1007/s00228-002-0490-1. Epub 2002 Jul 13. Eur J Clin Pharmacol. 2002. PMID: 12185559 Clinical Trial.

3

Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: a prospective survey in 300 adult cancer patients.

Klepstad P, Dale O, Kaasa S, Zahlsen K, Aamo T, Fayers P, Borchgrevink PC. Klepstad P, et al. Acta Anaesthesiol Scand. 2003 Jul;47(6):725-31. doi: 10.1034/j.1399-6576.2003.00138.x. Acta Anaesthesiol Scand. 2003. PMID: 12803591 Clinical Trial.

4

Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients.

Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P, Fougner B, Kaasa S. Klepstad P, et al. Palliat Med. 2003 Dec;17(8):679-87. doi: 10.1191/0269216303pm835oa. Palliat Med. 2003. PMID: 14694919

5

Day-to-day variations during clinical drug monitoring of morphine, morphine-3-glucuronide and morphine-6-glucuronide serum concentrations in cancer patients. A prospective observational study.

Klepstad P, Hilton P, Moen J, Kaasa S, Borchgrevink PC, Zahlsen K, Dale O. Klepstad P, et al. BMC Clin Pharmacol. 2004 Oct 4;4:7. doi: 10.1186/1472-6904-4-7. BMC Clin Pharmacol. 2004. PMID: 15461818 Free PMC article.

6

The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease.

Klepstad P, Rakvåg TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC, Baar C, Vikan T, Krokan HE, Skorpen F. Klepstad P, et al. Acta Anaesthesiol Scand. 2004 Nov;48(10):1232-9. doi: 10.1111/j.1399-6576.2004.00517.x. Acta Anaesthesiol Scand. 2004. PMID: 15504181

7

[Application of pupillometry and pupillary reactions in medical research].

Kjesbu SS, Moksnes K, Klepstad P, Knobel H, Kaasa S, Dale O. Kjesbu SS, et al. Among authors: klepstad p. Tidsskr Nor Laegeforen. 2005 Jan 6;125(1):29-32. Tidsskr Nor Laegeforen. 2005. PMID: 15643460 Free article. Review. Norwegian.

8

The European Union--not united in opioid use.

Dale O, Klepstad P, Kaasa S. Dale O, et al. Among authors: klepstad p. Palliat Med. 2005 Apr;19(3):177-8. doi: 10.1191/0269216305pm1012ed. Palliat Med. 2005. PMID: 15920929 No abstract available.

9

The Val158Met polymorphism of the human catechol-O-methyltransferase (COMT) gene may influence morphine requirements in cancer pain patients.

Rakvåg TT, Klepstad P, Baar C, Kvam TM, Dale O, Kaasa S, Krokan HE, Skorpen F. Rakvåg TT, et al. Among authors: klepstad p. Pain. 2005 Jul;116(1-2):73-8. doi: 10.1016/j.pain.2005.03.032. Pain. 2005. PMID: 15927391

10

Genetic variability and clinical efficacy of morphine.

Klepstad P, Dale O, Skorpen F, Borchgrevink PC, Kaasa S. Klepstad P, et al. Acta Anaesthesiol Scand. 2005 Aug;49(7):902-8. doi: 10.1111/j.1399-6576.2005.00772.x. Acta Anaesthesiol Scand. 2005. PMID: 16045647 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page